TAYLOR BECKHAM: Open Payments
NPI 1366212029 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,142 in 145 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $3,635 · 2025 $4,142
Food & beverage: $4,045Education: $97
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $801 |
| Regeneron Healthcare Solutions, Inc. | 15 | $653 |
| Janssen Biotech, Inc. | 16 | $469 |
| Novartis Pharmaceuticals Corporation | 20 | $424 |
| UCB, Inc. | 5 | $300 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $256 |
| GENZYME CORPORATION | 8 | $223 |
| Amgen Inc. | 10 | $221 |
| Organon LLC | 4 | $174 |
| Incyte Corporation | 7 | $165 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, Bimzelx, OTEZLA, COSENTYX, Winlevi.
Industry payments across AL — which companies pay providers there.
